PHN 081

Drug Profile

PHN 081

Alternative Names: PDC-748; PHN081

Latest Information Update: 18 Jun 2015

Price : $50

At a glance

  • Originator Pharmaceutical Industry Technology and Development Center; PhytoHealth; SunTen Phytotech
  • Developer PhytoHealth
  • Class Antitussives
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Cough

Most Recent Events

  • 16 Feb 2011 PHN 081 is still in phase II development for Cough in Taiwan
  • 31 May 2007 US FDA approves IND application for PDC 748 in Cough
  • 14 Jul 2006 Phase I/II clinical trials in Cough in Taiwan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top